With 150 colleagues at 3 sites in Ruelzheim, Frankfurt and Appenweier we look back on 30 years of experience.

We offer a service portfolio ranging from product development, analytical development and quality control, manufacturing of clinical batches and smaller market batches to drug safety and GxP services.

Together with network partners, HWI also supports clinical and preclinical studies.

Our technology platform for parenteral, nasal and oral applications focuses on the development of innovative and affordable drugs with a special focus on poorly soluble small and large molcules.

Our purpose is with novel technologies and innovative services to drive the development of highly effective medicines for everyone to improve peoples lives.

Imprint: https://www.hwi-group.de/en/imprint.html 
Data protection information: https://www.hwi-group.de/en/company/infocenter.html
GTC: https://www.hwi-group.de/en/company/infocenter.html

Life Sciences

HWI group

Dr. Stefan Wissel

Ellen W. Evelaar

Simone Kuntz

Nadine Lirtz

Gloria Magdalena Schmidt

Martin Blank

Magnus Nissel

Lilia Selinger

Dr. Lisa Held

Dr. Sandra Hürtgen

Christiane Wiegand

The Management team at HWI Group oversees strategic planning and decision-making across the organization. They ensure operational efficiency, drive business growth, manage key stakeholder relationships, and uphold the company's mission to develop innovative and affordable drugs. This team collaborates closely across departments to align objectives, optimize resources, and support the overall success and sustainability of the company.

Management

Pharmacovigilance Team

Management

About

Team members

Other teams at HWI group

Pharmacovigilance Team